EUVIMEDEUVIMED entdecken
Crossref

CD138 : A Potential Novel Diagnostic Marker for Cellular Neurothekeoma

Sarah Williamson iD, Arlene Rosenberg, Sarmad Jassim, Stephen Somach

Journal of Cutaneous Pathology · 2025-05 · 52 (5) · 379-383

DOI: 10.1111/cup.14790 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cutaneous Pathology, online erschienen am 03.03.2025. Verfasst von Sarah Williamson und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, MetroHealth Medical Center, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Neurothekeoma, Skin Neoplasms, Syndecan-1. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 6 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We incidentally observed CD138 (syndecan‐1) expression in a cellular neurothekeoma (CNT) and sought to investigate whether this is a consistent finding in these tumors.

Methods

We evaluated a series of 20 skin biopsy specimens diagnosed as CNT for CD138 immunohistochemical staining in comparison to the more traditional CNT immunohistochemical stains, NKI/C3 and MITF. Control cases of xanthogranuloma (XG), dermal Spitz nevi, and epithelioid fibrous histiocytomas (EFH) were included based on similar histopathologic morphology.

Results

CD138 expression in a membranous and reticulated extracellular pattern was observed in 95% of CNT cases evaluated. NKI/C3 was expressed in 83% of CNT, and MITF in 72%. Of the control cases, 10% of XG, 10% of dermal Spitz nevi, and 17% of EFH expressed CD138.

Conclusions

Our data suggest that CD138 may be a useful adjunctive marker in the diagnosis of CNT, particularly when utilized in a panel with other established markers such as NKI/C3 and MITF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorNeurothekeomaSkin NeoplasmsSyndecan-1HumansFemaleMaleMiddle AgedAdultImmunohistochemistryAged

Stichwörter der Autor:innen

CD138cellular neurothekeomaimmunohistochemistrysyndecan‐1

Substanzen

Biomarkers, TumorSyndecan-1SDC1 protein, human

Autor:innen und Institutionen

  • Department of Dermatology, MetroHealth Medical Center, Cleveland, Ohio, USA.
  • Department of Pathology, MetroHealth Medical Center, Cleveland, Ohio, USA.

ORCID-Profile: Sarah Williamson

Zitieren

APA

Williamson, S., Rosenberg, A., Jassim, S., & Somach, S. (2025). CD138 : A Potential Novel Diagnostic Marker for Cellular Neurothekeoma. Journal of Cutaneous Pathology, 52(5), 379-383. https://doi.org/10.1111/cup.14790

Vancouver

Williamson S, Rosenberg A, Jassim S, Somach S. CD138 : A Potential Novel Diagnostic Marker for Cellular Neurothekeoma. Journal of Cutaneous Pathology. 2025;52(5):379-383. doi:10.1111/cup.14790

BibTeX
@article{Williamson2025,
  author = {Williamson, Sarah and Rosenberg, Arlene and Jassim, Sarmad and Somach, Stephen},
  title = {CD138 : A Potential Novel Diagnostic Marker for Cellular Neurothekeoma},
  journal = {Journal of Cutaneous Pathology},
  year = {2025},
  volume = {52},
  number = {5},
  pages = {379--383},
  doi = {10.1111/cup.14790}
}
Kostenlos starten →